Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin vs Tigecycline for MDR Gram-Negative Bacteria
NCT06893835Phase 4Active, not recruiting
- Sponsor
- Beni Suef University
- Start
- Dec 2024
- Primary completion
- May 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of colistimethate sodium, tigecycline in Gram-negative bacterial infection, sponsored by Beni Suef University. Started Dec 2024; status: active, not recruiting.
02
Drugs
colistimethate sodiumtigecycline
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on NCT06893835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06893835.